“The speculative-grade rating reflects the district’s significant and sustained financial challenges characterized by extremely light liquidity, which has deteriorated swiftly over the past two years,” said S&P analyst Patrick Zagar.
The outlook is negative, reflecting S&P Global Ratings’ opinion the district’s available liquidity provides little to no cushion for any unforeseen operational challenges that may arise. S&P also said the district’s weak economic activity and demographics, limited revenue base and material reliance on supplemental funding may make it more vulnerable to reimbursement changes.
More articles on healthcare finance:
The accessibility, accuracy and actionability of cost information
Moody’s affirms ‘A3’ rating on Roper St. Francis Healthcare’s bonds
33 hospital outlook and credit rating actions in May
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
